What is the impact of respiratory diseases on neonates?
Answer from top 10 papers
Respiratory diseases in neonates are a significant health concern, as they are major contributors to neonatal morbidity and mortality, particularly in preterm infants (Baseer et al., 2020; Poddutoor et al., 2011). The prevalence of respiratory diseases in neonates is high, with respiratory distress syndrome (RDS) being the most common, followed by conditions such as transient tachypnea of the newborn (TTN), pneumonia, and meconium aspiration syndrome (MAS) (Ciuffini et al., 2014; Poddutoor et al., 2011). Risk factors for these diseases include premature rupture of membranes (PROM), maternal diabetes, fetal prematurity (Poddutoor et al., 2011), and mother's illnesses like hypertension and diabetes (Cannavò et al., 2021). Additionally, oxidative stress plays a role in the pathogenesis of chronic lung diseases like bronchopulmonary dysplasia (BPD) (Qari et al., 2018).
Interestingly, while RDS carries the highest risk of mortality, TTN has the highest survival rate among the respiratory conditions (Poddutoor et al., 2011). Moreover, the use of pulmonary surfactants has been shown to reduce neonatal mortality and the need for mechanical ventilation (Nadagouda et al., 2020). Diagnostic tools such as chest X-rays and lung ultrasound play a crucial role in identifying respiratory disorders in neonates (Ciuffini et al., 2014; Liu et al., 2013). High-frequency oscillatory ventilation (HFOV) has been noted to improve oxygenation and ventilation in neonates with acute respiratory failure (Snisar et al., 2015).
In summary, respiratory diseases are a critical issue in neonatal care, with a variety of risk factors and outcomes. The use of non-invasive diagnostic methods and treatments like pulmonary surfactants and HFOV can improve the management of these conditions (Baseer et al., 2020; Nadagouda et al., 2020; Snisar et al., 2015). Continued research and development of individualized care strategies, including the understanding of oxidative stress, are essential for improving the prognosis of affected neonates (Qari et al., 2018).
Source Papers